Richard M Bergenstal Selected Research

Richard M Bergenstal Research Topics

Disease

66	Type 2 Diabetes Mellitus (MODY) 01/2022 - 08/2005
47	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2022 - 04/2005
37	Hypoglycemia (Reactive Hypoglycemia) 01/2022 - 08/2005
9	Diabetic Ketoacidosis (Ketoacidosis, Diabetic) 01/2022 - 12/2012
8	Hyperglycemia 01/2022 - 04/2015
8	Weight Loss (Weight Reduction) 04/2019 - 03/2008
7	Weight Gain 04/2019 - 03/2008
7	Acute Coronary Syndrome 08/2018 - 10/2011
7	Body Weight (Weight, Body) 10/2017 - 03/2008
4	Stroke (Strokes) 11/2019 - 01/2016
4	Myocardial Infarction 11/2019 - 10/2013
4	Obesity 10/2017 - 06/2009
4	Pancreatitis 01/2016 - 07/2011
4	Neoplasms (Cancer) 10/2013 - 07/2010
3	Ketosis 01/2022 - 04/2015
3	Heart Failure 11/2019 - 01/2016
3	Cardiovascular Diseases (Cardiovascular Disease) 04/2016 - 11/2013
3	Inflammation (Inflammations) 07/2015 - 07/2011
3	Overweight 11/2013 - 03/2008
3	Nausea 01/2011 - 05/2010
2	Coma (Comas) 04/2021 - 12/2012
2	Diabetes Complications 01/2021 - 11/2018
2	Insulin Resistance 12/2018 - 09/2009
2	Unstable Angina 08/2018 - 10/2013
2	Coronary Disease (Coronary Heart Disease) 01/2017 - 01/2016
2	Pain (Aches) 03/2015 - 04/2003
1	Bone Fractures (Bone Fracture) 11/2019
1	Belonephobia 01/2019
1	Chronic Kidney Failure (Chronic Renal Failure) 04/2016
1	Obstructive Sleep Apnea 01/2016
1	Sleep Apnea Syndromes (Sleep Apnea) 01/2016
1	Infections 07/2015
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 06/2014
1	Kidney Diseases (Kidney Disease) 10/2013
1	Injection Site Reaction 12/2012

Drug/Important Bio-Agent (IBA)

64	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 09/2005
63	Insulin (Novolin)FDA Link 01/2022 - 04/2005
24	Insulin Glargine (Lantus)FDA Link 11/2021 - 03/2008
16	Hypoglycemic Agents (Hypoglycemics)IBA 01/2022 - 08/2005
14	Metformin (Glucophage)FDA LinkGeneric 01/2022 - 03/2008
12	Blood Glucose (Blood Sugar)IBA 01/2022 - 04/2003
11	Exenatide (Byetta)FDA Link 04/2019 - 03/2008
9	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 04/2016 - 04/2005
7	alogliptinIBA 08/2018 - 10/2011
6	Dipeptidyl-Peptidase IV InhibitorsIBA 01/2022 - 06/2009
5	IncretinsIBA 01/2022 - 06/2009
5	Liraglutide FDA Link 01/2016 - 06/2009
4	insulin degludecIBA 01/2022 - 09/2013
4	Peptides (Polypeptides)IBA 01/2022 - 06/2009
4	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2022 - 12/2012
4	lixisenatideIBA 10/2017 - 11/2016
4	LY2605541IBA 01/2014 - 11/2012
4	Sitagliptin Phosphate (Januvia)FDA Link 12/2012 - 06/2009
3	Glucagon-Like Peptide-1 ReceptorIBA 01/2022 - 07/2011
3	InsulinsIBA 01/2021 - 12/2015
3	Hemoglobins (Hemoglobin)IBA 04/2019 - 09/2005
2	Short-Acting InsulinIBA 04/2021 - 01/2016
2	omega-Chloroacetophenone (Mace)IBA 11/2019 - 01/2017
2	C-PeptideIBA 12/2016 - 04/2016
2	SuspensionsIBA 05/2015 - 07/2013
2	Pioglitazone (Actos)FDA Link 01/2011 - 08/2010
2	Biological ProductsIBA 07/2010 - 07/2010
2	Glucagon-Like Peptide-1 Receptor AgonistsIBA 07/2009 - 06/2009
2	VildagliptinIBA 07/2009 - 06/2009
2	CarbohydratesIBA 07/2008 - 04/2003
1	KetonesIBA 01/2022
1	DKA 9IBA 01/2022
1	tirzepatideIBA 01/2022
1	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2022
1	insulin icodecIBA 01/2021
1	Insulin Lispro (Humalog)FDA Link 11/2020
1	empagliflozinIBA 11/2019
1	Sodium-Glucose Transport ProteinsIBA 04/2019
1	SolutionsIBA 03/2019
1	(L)-Isomer Glucose (L-Glucose)IBA 07/2017
1	Insulin Aspart (NovoLog)FDA Link 01/2017
1	DiamondIBA 01/2017
1	FructosamineIBA 04/2016
1	AlbuminsIBA 04/2016
1	Biomarkers (Surrogate Marker)IBA 04/2016
1	Oxygen (Dioxygen)IBA 01/2016
1	basal insulin peglisproIBA 01/2016
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2016
1	AS 8IBA 03/2015
1	Amylases FDA Link 11/2014
1	Lipase (Acid Lipase)FDA Link 11/2014
1	Long-Acting Insulin (Insulin, Long Acting)FDA Link 01/2014
1	Glucagon-Like Peptide ReceptorsIBA 11/2013
1	Pharmaceutical PreparationsIBA 11/2013
1	Cardiovascular AgentsIBA 10/2013
1	Dipeptidyl Peptidase 4 (Dipeptidyl Peptidase IV)IBA 10/2013
1	taspoglutideIBA 12/2012
1	Isophane Insulin (NPH Insulin)FDA Link 11/2012
1	Hemoglobin AIBA 11/2012

Therapy/Procedure

36	Therapeutics 01/2022 - 08/2005
29	Glycemic Control 01/2022 - 08/2005
7	Injections 01/2021 - 07/2010
1	Ambulatory Care (Outpatient Care) 01/2021
1	Activities of Daily Living (ADL) 12/2016
1	Critical Care (Surgical Intensive Care) 07/2015